Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA 2021-05-25 08:30
Antengene Appoints Kathryn Gregory as Vice President and Head of Corporate Business Development 2021-05-25 08:00
Lifebit Awarded A Four-Year Contract for Hong Kong's Genome Project 2021-05-25 06:00
Biovaxys Strengthens Internal Expertise With Appointment Of Scientific Advisor For Ovarian Cancer Vaccine Clinical Program And Papilocare Marketing 2021-05-24 20:00
Seegene introduces an exclusive diagnostic system for diagnosing COVID-19 variants at ECCMID 2021-05-24 09:58
A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal 2021-05-24 08:16
DocuSign, the global leader in document management, partnered with Trans Sped one of the most dynamic digital transformation companies in Romania 2021-05-24 07:00
Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea 2021-05-23 00:39
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine 2021-05-23 00:00
Recently Merged dMed and Clinipace Announce the Appointment of New Global COO 2021-05-21 20:00
Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation LLC Announce Launch of Seoul Innovation QuickFire Challenge on Smart Surgery in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute 2021-05-21 05:00
BioVaxys Announces Appointment of Policy Advisor 2021-05-20 20:00
Regent Pacific's Deep Longevity Announces Partnership with LifeHub & LifeClinic in Hong Kong 2021-05-20 12:00
Kintor Announced (1) FDA Has Greenlighted Proxalutamide's Phase III Study for Hospitalized Male and Female COVID-19 Patients to Be Conducted; and (2) Inclusion of Female Outpatients in Proxalutamide's Phase III Study for Mild to Moderate COVID-19 2021-05-20 09:47
ASCO 2021 | Ascentage Pharma to Announce Updated Data of Lisaftoclax (APG-2575) Demonstrating an ORR of Around 80% and Therapeutic Potential in Patients with R/R CLL/SLL in Oral Presentation 2021-05-20 08:44
ASCO 2021 | Ascentage Pharma to Announce Updated Results Demonstrating Clinical Potential of Alrizomadlin (APG-115) Plus Pembrolizumab in Patients with Advanced Solid Tumors that Had Failed Immunotherapies in Oral Presentation 2021-05-20 08:17
Duality Biologics Completed $90 Million Series B Financing 2021-05-20 08:00
I-Mab Presents Phase 1 Data on Highly Differentiated CD73 Antibody Uliledlimab at ASCO 2021 2021-05-20 06:00
Gracell Biotechnologies to Present Updated Results of GC012F FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma at ASCO 2021 and EHA 2021 2021-05-20 05:15
ThinkCyte Secures $26 million in Series B Financing 2021-05-19 22:00
1 146 147 148 149 150